ONCOMATCH
LIVE

Serial Number

99112527

Owner

Revvity Discovery Limited

Attorney

Kevin Oliver

Filing Date

Mar 31, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ONCOMATCH Trademark

Serial Number: 99112527

ONCOMATCH is a trademark filed by Revvity Discovery Limited on March 31, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently pending registration.

Owner Contact Info

Revvity Discovery Limited

8100 Cambridge Research Park, Waterbeach
Cambridge CB25 9TL , GB

Entity Type: 99

Trademark Details

Filing Date

March 31, 2025

Registration Date

Not Registered

Published for Opposition

February 17, 2026

Goods & Services

cell line-derived reference standards used in clinical samples in the nature of biological preparations for use in cell cultures for medical purposes; Reference standard substances being reagents used for clinical tests for medical purposes; Reference standards being reagents used for next generation DNA sequencing and/or Polymerase chain reaction (PCR) testing for medical purposes; Reference standards being diagnostic preparations for medical purposes specifically for detecting chromosomal abnormalities; Reference standards being diagnostic preparations for medical purposes specifically for analyzing biological samples for medical purposes

Custom manufacture of cell line-delivered products being biological preparations for medical and commercial applications; Custom manufacture of reference standards being biological preparations for use in industry and science

Biological preparations for use in industry and science specifically for use in research laboratories, biopharmaceutical and research purposes specifically as reference standards; Biological preparations for use in industry and science specifically cancer research; Biological preparations for use in industry and science specifically for use in quality control applications; Biological preparations for use in industry and science specifically cultured ex vivo cell lines for use as reference standards for research purpose; Samples being biological preparations for use in industry and science specifically for biochemical or biological laboratory analysis for research purposes; Cell line-derived products namely, reagents for scientific and research purposes specifically for clinical investigations and for use in product testing; Reference standards being reagents used for research purposes, namely, next generation sequencing, droplet-digital, Real-Time PCR or Sanger sequencing;

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 23, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 11, 2025 GNFN
FINAL REFUSAL E-MAILED
Nov 11, 2025 GNFR
FINAL REFUSAL WRITTEN
Nov 11, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 14, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 13, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 13, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 7, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 31, 2025 MAFR
NEW APPLICATION ENTERED
Mar 31, 2025 NWAP